Last update 02 Sep 2025

Alteplase Biosimilar(Generium)

Overview

Basic Info

Drug Type
Biosimilar, Enzyme
Synonyms
Revelise
Target
PLG
Action
stimulants
Mechanism
PLG stimulants(Plasminogen stimulants)
Therapeutic Areas
Cardiovascular Diseases
Active Indication-
Inactive Indication
Acute myocardial infarctionST Elevation Myocardial Infarction
Originator Organization
Generium ZAOGenerium ZAO
Active Organization-
Inactive Organization
Generium ZAOGenerium ZAO
License Organization-
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Related

1
Clinical Trials associated with Alteplase Biosimilar(Generium)
NCT07146360
/ CompletedPhase 3
A Multi-center, Randomized, Single-blind, Parallel Group Clinical Trial to Evaluate the Efficacy and Safety of the Revelise® (GENERIUM, Russia) as Compared With the Actilyse® (Boehringer Ingelheim Pharma GmbH and Co.KG, Germany) in Patients With Acute Myocardial Infarction With ST-segment Elevation on ECG
100 Clinical Results associated with Alteplase Biosimilar(Generium)
Login to view more data
100 Translational Medicine associated with Alteplase Biosimilar(Generium)
Login to view more data
100 Patents (Medical) associated with Alteplase Biosimilar(Generium)
Login to view more data
100 Deals associated with Alteplase Biosimilar(Generium)
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
B01AD02S01XA13
-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute myocardial infarctionPhase 3
Russia
Generium ZAOGenerium ZAO
25 May 2014
ST Elevation Myocardial InfarctionPhase 3
Russia
Generium ZAOGenerium ZAO
25 May 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free